Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Talis Biomedical Corporation - common stock (NQ: TLIS )

4.380 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Talis Biomedical Corporation - common stock

< Previous 1 2 3 4 5 6 Next >
TLIS CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Lawsuit Against Talis Biomedical Corporation
From Glancy Prongay & Murray LLP
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this... 
Via Benzinga
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
Why Are Talis Shares Trading Higher Today?
The 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 26.54% to $5.12 during Wednesday's regular session. Trading volume for Virpax Pharmaceuticals's... 
Via Benzinga
80 Biggest Movers From Yesterday
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares surged 55% to close at $1.00 on Tuesday as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG)... 
Via Benzinga
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis... 
Via Benzinga
Talis Biomedical Corporation (TLIS) Q3 2021 Earnings Call Transcript
TLIS earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
NASDAQ:TLIS Investor Notice: Investigation over Potential Wrongdoing at Talis Biomedical Corporation
San Diego, CA -- (SBWIRE) -- 11/05/2021 -- Certain directors of Talis Biomedical Corporation are under investigation concerning potential breaches of fiduciary duties. 
Via SBWire
Topics Earnings
Exposures COVID-19 Financial
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Keros Therapeutics (NASDAQ:KROS) stock moved upwards by 26.51% to $41.75 during Monday's regular session. Keros Therapeutics's stock is trading at a volume... 
Via Benzinga
Earnings Scheduled For November 15, 2021
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter. • Tyson Foods (NYSE:TSN) is estimated to... 
Via Benzinga
64 Biggest Movers From Yesterday
Gainers Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares jumped 219% to close at $10.40 on Monday after the company announced the launch of its E-Boost portfolio of mobile... 
Via Benzinga
NASDAQ:TLIS Investor Notice: Investigation over Possible Securities Laws Violations by Talis Biomedical Corporation
San Diego, CA -- (SBWIRE) -- 09/15/2021 -- Talis Biomedical Corporation is under investigation concerning potential securities laws violations in connection with certain financial statements. 
Via SBWire
Topics Earnings
Exposures COVID-19 Financial
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... 
Via Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (... 
Via Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 27) Acceleron Pharma Inc. (... 
Via Benzinga
Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021
Upgrades According to Roth Capital, the prior rating for Seelos Therapeutics Inc (NASDAQ: 
Via Benzinga
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics... 
Via Benzinga
Exposures COVID-19
TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis on Behalf of Talis Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Continues Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
55 Biggest Movers From Yesterday
Gainers Unico American Corporation (NASDAQ: UNAM) shares gained 59% to close at $4.15 on Tuesday. Elys Game Technology, Corp. (NASDAQ: ELYS) rose 43% to close at $6.62 after it... 
Via Benzinga
The Law Offices of Frank R. Cruz Announces Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
33 Stocks Moving In Tuesday's Mid-Day Session
Gainers AC Immune SA (NASDAQ: ACIU) shares jumped 68.4% to $11.77. AC Immune and its collaborating partner Genentech, part of Roche Holdings, announced topline data from Phase 2... 
Via Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.